JANSITIN DUO

This brand name is authorized in Estonia, Malta, Romania

Active ingredients

The drug JANSITIN DUO contains a combination of these active pharmaceutical ingredients (APIs):

1 Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia. Read about Metformin

2 Sitagliptin UNII 6DH2XG35TG - SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE

Sitagliptin is a member of a class of oral anti-hyperglycaemic agents called dipeptidyl peptidase 4 (DPP-4) inhibitors. The improvement in glycaemic control observed with this medicinal product may be mediated by enhancing the levels of active incretin hormones. Read about Sitagliptin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BD07	Metformin and sitagliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1810572, 1810583, 1810594, 1810606, 1810617, 1810628, 1810639, 1810640, 1810651, 1810662, 1810673, 1810684
Country: MT	Medicines Authority	Identifier(s): MA993/00601, MA993/00602
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69236001, W69236002, W69236003, W69236004, W69236005, W69236006, W69237001, W69237002, W69237003, W69237004, W69237005, W69237006